Avax Technologies Overview

  • Status
  • Public
  • Employees
  • 29
  • Stock Symbol
  • AVXT
Stock Symbol

Avax Technologies General Information


Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 2000 Hamilton Street
  • Philadelphia, PA 19130
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avax Technologies Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Avax Technologies Financials Summary

In Thousands,
TTM 30-Sep-2008 FY 2007 31-Dec-2007 FY 2006 31-Dec-2006 FY 2005 31-Dec-2005
EV 6,073 8,358 6,035 8,860
Revenue 735 617 735 1,624
EBITDA (11,805) (6,113) (5,065) (3,389)
Net Income (7,378) (6,414) (5,356) (3,704)
Total Assets 1,367 7,377 3,044 7,348
Total Debt 362 325
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avax Technologies Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avax Technologies‘s full profile, request access.

Request a free trial

Avax Technologies Executive Team (5)

Name Title Board Seat Contact Info
Howard Fischer Chief Financial Officer & Board Member
To view Avax Technologies’s complete executive team members history, request access »

Avax Technologies Board Members (1)

Name Representing Role Since
000000 0000000 Avax Technologies Chief Financial Officer & Board Member 000 0000
To view Avax Technologies’s complete board members history, request access »

Avax Technologies Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial